Acquisitions & Divestments

The list below offers extensive information about our past acquisitions and divestments.

Acquisitions

Name of Company
Transaction costs
Year Business Sector
Press Release
Mirus Bio € 550 m 2024 Life Science Further Information
Mecaro Co. Ltd. € 110 m 2022 Electronics Further Information
MAST n/a 2022 Life Science Further Information
Exelead $ 780 m 2022 Life Science Further Information
Chord Therapeutics n/a 2022 Healthcare Further Information
Amptec n/a 2021 Life Science Further Information
Resolution Spectra Systems n/a 2020 Life Science Further Information
FloDesign Sonics n/a 2019 Life Science Further information
Intermolecular $ 62 m 2019 Electronics Further information
Versum Materials € 5.8 bn 2019 Electronics Further information
Natrix Separations n/a 2017 Life Science n/a
BioControl
 n/a 2017 Life Science
 n/a
Sigma-Aldrich
 € 13.1 bn
 2015 Life Science
 Further information
Ormet Circuits
 n/a 2015 Electronics n/a
Qlight Nanotech
 n/a
 2015 Electronics n/a
Peer+
 n/a 2014 Electronics n/a
AZ Electronics
 € 1.9 bn
 2014 Electronics n/a
Biochrom AG
 n/a
 2012 Life Science
 n/a
CellASIC (USA)
 n/a 2012 Life Science
 n/a
Amnis (USA)
 n/a
 2011 Life Science
 n/a
heipha Dr. Müller GmbH/Hycon branch of Biotest AG
 n/a
 2011 Life Science
 n/a
Beijing Skywing Technology (China)
 € 14.5 m
 2010 Life Science
 n/a
Millipore Corporation (US)
 € 5.1 bn
 2010 Life Science
 n/a
Taizhu (China)
 € 26.3 m
 2009 Electronics n/a
Bio-Fyt Pharma (Belgium)
 € 30.0 m
 2008 Healthcare
 n/a
SeQuant
 € 6.9 m
 2008 Life Science
 n/a
Serono (Switzerland)
 € 10.3 bn
 2006 Healthcare
 n/a
Agribiotics Holdings (Canada)
 € 21.9 m
 2006 Electronics n/a
Survac (Denmark)
 € 10.8 m
 2005 Healthcare
 n/a
OLED and polymer electronics activities from Avecia (UK) incl. Covion (Germany)
 € 49.3 m
 2005 Electronics n/a
NM Pharma (Scandinavia)
 € 49,1 m
 2004
 divested with EMD Generics
 n/a
Nature's Best, VMS mail order (UK)
 € 22,8 m
 2003 Healthcare
 n/a
Laboratoires Richelet (France)
 € 9.3 m
 2002 Healthcare
 n/a

Divestments

Name of Company
Transaction costs
Year Business
Press Release
Allergopharma n/a 2020 Healthcare Further information
Biosimilars Business n/a 2017 Healthcare Further information
Pakistan Healthcare Business of Merck KGaA, Darmstadt, Germany
 n/a 2016 Healthcare
 n/a
Discovery and Development Solutions
 € 22.6 m
 2015 Life Science
 n/a
Mobile Energy Business (Germany)
 n/a 2012 Electronics n/a
Crop BioScience Business (USA, Canada & Argentina)
 € 208.2 m
 2010 EMD Serono
 n/a
Théramex (Monaco & Italien)
 € 269.3 m
 2010 EMD Serono n/a
EMD Generics Division
 € 4.9 bn
 2007 n/a n/a
ITO/CF Business (Taiwan)
 € 29 m
 2006 Electronics n/a
Electronic Chemicals Business
 € 270 m
 2005 Electronics n/a
Lab distribution VWR (US)
 $ 1.68 bn
 2004 n/a n/a
50% holding of Biomet-Merck KGaA, Darmstadt, Germany
 $ 300 m
 2004 Electronics n/a
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.
investors-webcast investors-webcast
Webcasts & Presentations
learn more
Webcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
Unrecognizable business people examining financial reports and analyzing business growth Unrecognizable business people examining financial reports and analyzing business growth
Analysts & Consensus
Read More
Analysts & Consensus
Several banks and brokerages regularly cover Merck KGaA, Darmstadt, Germany, by publishing analyses, short reviews and updates. An accurate and up to date consensus of these various projections is provided by VARA Research once per quarter.